About Index Trending news
Analyze
Top 50 Pricing
Immunovaccine Inc.

Immunovaccine Inc.

Work at Immunovaccine Inc.? Add yourself to this profile

Immunovaccine Inc.

Immunovaccine Inc. (TSX-V: IMV) develops vaccines, using its patented delivery platform – DepoVax™ – for therapeutic cancer and infectious diseases.

Elsewhere

Alexa global traffic share

Twitter followers

05 Sep 2014
$11,200,000
Post-IPO equity